日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug-induced pneumonitis risk in diffuse large B-cell/follicular lymphoma patients treated with R-CHOP-like regimen is associated with the use of granulocyte colony-stimulating growth factors

接受 R-CHOP 样方案治疗的弥漫性大 B 细胞/滤泡性淋巴瘤患者发生药物性肺炎的风险与粒细胞集落刺激生长因子的使用相关。

Kaprio, Elina; Prusila, Roosa; Tokola, Susanna; Kuusisto, Milla E L; Jantunen, Esa; Kuitunen, Hanne; Turpeenniemi-Hujanen, Taina; Kuittinen, Outi

Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice

临床实践中接受一线、二线和三线治疗的滤泡性淋巴瘤患者的无进展生存期

Rajamaki, Aino; Sorigue, Marc; Prusila, Roosa E I; Kuusisto, Milla E L; Kuitunen, Hanne; Jantunen, Esa; Mercadal, Santiago; Turpeenniemi-Hujanen, Taina; Sancho, Juan-Manuel; Sunela, Kaisa; Kuittinen, Outi

Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria

真实世界数据:MCL2方案在不符合原试验入组标准的套细胞淋巴瘤患者中显示出优异的治疗效果

Harmanen, Minna; Klaavuniemi, Tuula; Sorigue, Marc; Khan, Madiha; Prusila, Roosa; Kari, Esa; Alanne, Erika; Rajamäki, Aino; Sunela, Kaisa; Jukkola, Arja; Jantunen, Esa; Sancho, Juan-Manuel; Ketola, Sanna; Kuitunen, Hanne; Selander, Tuomas; Rönkä, Aino; Kuittinen, Outi

Estimating the Lifetime Treatment Burden of Patients With Follicular Lymphoma: A Retrospective Study Using Real-World Multicenter Data

利用真实世界多中心数据进行回顾性研究,评估滤泡性淋巴瘤患者的终生治疗负担

Rajamäki, Aino; Hujo, Mika; Sund, Reijo; Prusila, Roosa E I; Kuusisto, Milla E L; Kuitunen, Hanne; Jantunen, Esa; Mercadal, Santiago; Sorigue, Marc; Sancho, Juan-Manuel; Sunela, Kaisa; Kuittinen, Outi

Mortality among patients with low-grade follicular lymphoma: A binational retrospective analysis

低级别滤泡性淋巴瘤患者死亡率:一项双边回顾性分析

Rajamäki, Aino; Hujo, Mika; Sund, Reijo; Prusila, Roosa E I; Kuusisto, Milla E L; Kuitunen, Hanne; Jantunen, Esa; Mercadal, Santiago; Sorigue, Marc; Sancho, Juan-Manuel; Sunela, Kaisa; Kuittinen, Outi